{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:05:00Z","timestamp":1790366700970,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1124\/jpet.110.173187","type":"journal-article","created":{"date-parts":[[2010,9,10]],"date-time":"2010-09-10T04:14:50Z","timestamp":1284092090000},"page":"562-571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Differential Activation of Pregnane X Receptor and Constitutive Androstane Receptor by Buprenorphine in Primary Human Hepatocytes and HepG2 Cells"],"prefix":"10.1016","volume":"335","author":[{"given":"Linhao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem E.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia H.","family":"Tolson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie D.","family":"Eddington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.110.173187_bib1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/jpet.109.159210","article-title":"A single amino acid controls the functional switch of human constitutive androstane receptor (CAR) 1 to the xenobiotic-sensitive splicing variant CAR3","volume":"332","author":"Chen","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.173187_bib2","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1124\/dmd.109.027029","article-title":"In vitro and in vivo induction of cytochrome P450: a survey of the current practices and recommendations: a Pharmaceutical Research and Manufacturers of America perspective","volume":"37","author":"Chu","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.173187_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jat\/27.2.57","article-title":"Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases","volume":"27","author":"Cone","year":"2003","journal-title":"J Anal Toxicol"},{"key":"10.1124\/jpet.110.173187_bib4","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0090-9556(25)07765-7","article-title":"The metabolism and excretion of buprenorphine in humans","volume":"12","author":"Cone","year":"1984","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.173187_bib5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00003088-200544070-00001","article-title":"Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence","volume":"44","author":"Elkader","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.110.173187_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/jpet.106.112136","article-title":"Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers","volume":"320","author":"Faucette","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.173187_bib7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cellsig.2005.07.007","article-title":"Role of CYP3A4 in the regulation of the aryl hydrocarbon receptor by omeprazole sulphide","volume":"18","author":"Gerbal-Chaloin","year":"2006","journal-title":"Cell Signal"},{"key":"10.1124\/jpet.110.173187_bib8","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1002\/jps.21770","article-title":"Differential involvement of P-glycoprotein (ABCB1) in permeability, tissue distribution, and antinociceptive activity of methadone, buprenorphine, and diprenorphine: in vitro and in vivo evaluation","volume":"98","author":"Hassan","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.110.173187_bib9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jbt.20175","article-title":"Human metabolic interactions of environmental chemicals","volume":"21","author":"Hodgson","year":"2007","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1124\/jpet.110.173187_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/07853890310008224","article-title":"Drug-activated nuclear receptors CAR and PXR","volume":"35","author":"Honkakoski","year":"2003","journal-title":"Ann Med"},{"key":"10.1124\/jpet.110.173187_bib11","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0024-3205(97)00160-4","article-title":"Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomes","volume":"60","author":"Iribarne","year":"1997","journal-title":"Life Sci"},{"key":"10.1124\/jpet.110.173187_bib12","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0376-8716(03)00060-7","article-title":"Buprenorphine: how to use it right","volume":"70","author":"Johnson","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.110.173187_bib13","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1128\/MCB.19.9.6318","article-title":"Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene","volume":"19","author":"Kawamoto","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.110.173187_bib14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.clpt.2004.05.003","article-title":"Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone","volume":"76","author":"Kharasch","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.110.173187_bib15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/er.2001-0038","article-title":"The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism","volume":"23","author":"Kliewer","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1124\/jpet.110.173187_bib16","doi-asserted-by":"crossref","first-page":"504","DOI":"10.5414\/CPP38504","article-title":"Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use","volume":"38","author":"K\u00f6hler","year":"2000","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1124\/jpet.110.173187_bib17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejpain.2008.04.011","article-title":"Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine","volume":"13","author":"Kress","year":"2009","journal-title":"Eur J Pain"},{"key":"10.1124\/jpet.110.173187_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0928-0987(01)00135-X","article-title":"Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation","volume":"13","author":"LeCluyse","year":"2001","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/jpet.110.173187_bib19","first-page":"207","article-title":"Isolation and culture of primary human hepatocytes","volume":"290","author":"LeCluyse","year":"2005","journal-title":"Methods Mol Biol"},{"key":"10.1124\/jpet.110.173187_bib20","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1124\/dmd.108.026005","article-title":"Nuclear translocation of adenoviral-enhanced yellow fluorescent protein-tagged-human constitutive androstane receptor (hCAR): a novel tool for screening hCAR activators in human primary hepatocytes","volume":"37","author":"Li","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.173187_bib21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1124\/mol.108.046656","article-title":"The peripheral benzodiazepine receptor ligand 1-(2-chlorophenyl-methylpropyl)-3-isoquinoline-carboxamide is a novel antagonist of human constitutive androstane receptor","volume":"74","author":"Li","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.110.173187_bib22","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s11095-008-9788-8","article-title":"Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways","volume":"26","author":"Li","year":"2009","journal-title":"Pharm Res"},{"issue":"Suppl 4","key":"10.1124\/jpet.110.173187_bib23","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/508187","article-title":"Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine","volume":"43","author":"McCance-Katz","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"10.1124\/jpet.110.173187_bib24","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1086\/508188","article-title":"Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir\/ritonavir, and ritonavir","volume":"43","author":"McCance-Katz","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1124\/jpet.110.173187_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/15360280902900869","article-title":"Buprenorphine for opioid dependence","volume":"23","author":"Milne","year":"2009","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"10.1124\/jpet.110.173187_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.drugalcdep.2004.10.008","article-title":"Opioid abuse and cognitive performance","volume":"78","author":"Mintzer","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.110.173187_bib27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00003495-200969050-00006","article-title":"Buprenorphine\/naloxone: a review of its use in the treatment of opioid dependence","volume":"69","author":"Orman","year":"2009","journal-title":"Drugs"},{"key":"10.1124\/jpet.110.173187_bib28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1533-2500.2008.00204.x","volume":"8","author":"Pergolizzi","year":"2008","journal-title":"Pain Pract"},{"key":"10.1124\/jpet.110.173187_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2174\/1389200054633899","article-title":"CAR, the continuously advancing receptor, in drug metabolism and disease","volume":"6","author":"Qatanani","year":"2005","journal-title":"Curr Drug Metab"},{"key":"10.1124\/jpet.110.173187_bib30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/dmd.31.5.533","article-title":"Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products","volume":"31","author":"Raucy","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.173187_bib31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/138920006776873535","article-title":"Evaluation of 170 xenobiotics as transactivators of human pregnane X receptor (hPXR) and correlation to known CYP3A4 drug interactions","volume":"7","author":"Sinz","year":"2006","journal-title":"Curr Drug Metab"},{"key":"10.1124\/jpet.110.173187_bib32","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1124\/jpet.105.090795","article-title":"Differential UGT1A1 induction by chrysin in primary human hepatocytes and HepG2 Cells","volume":"315","author":"Smith","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.173187_bib33","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1124\/dmd.109.027854","article-title":"Methadone induces the expression of hepatic drug-metabolizing enzymes through the activation of pregnane X receptor and constitutive androstane receptor","volume":"37","author":"Tolson","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.173187_bib34","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0090-9556(24)15189-6","article-title":"Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in the human hepatoma cell line hep G2","volume":"28","author":"Walle","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.173187_bib35","doi-asserted-by":"crossref","first-page":"29295","DOI":"10.1074\/jbc.M400580200","article-title":"Human constitutive androstane receptor mediates induction of CYP2B6 gene expression by phenytoin","volume":"279","author":"Wang","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.110.173187_bib36","doi-asserted-by":"crossref","first-page":"14146","DOI":"10.1074\/jbc.M212482200","article-title":"A novel distal enhancer module regulated by pregnane X receptor\/constitutive androstane receptor is essential for the maximal induction of CYP2B6 gene expression","volume":"278","author":"Wang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.110.173187_bib37","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2165\/00003088-200342150-00003","article-title":"Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes","volume":"42","author":"Wang","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.110.173187_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrd753","article-title":"PXR, CAR and drug metabolism","volume":"1","author":"Willson","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.110.173187_bib39","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1101\/gad.846800","article-title":"Reciprocal activation of xenobiotic response genes by nuclear receptors SXR\/PXR and CAR","volume":"14","author":"Xie","year":"2000","journal-title":"Genes Dev"},{"key":"10.1124\/jpet.110.173187_bib40","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/mol.106.029264","article-title":"The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor","volume":"71","author":"Zhou","year":"2007","journal-title":"Mol Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524461235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524461235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.110.173187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:21:29Z","timestamp":1740018089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524461235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0022356524461235"],"URL":"https:\/\/doi.org\/10.1124\/jpet.110.173187","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential Activation of Pregnane X Receptor and Constitutive Androstane Receptor by Buprenorphine in Primary Human Hepatocytes and HepG2 Cells","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.110.173187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}